LARGE CAP PSYCH

    Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic...

    Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.

    MindMed (MNMD) and Liechti Lab Provide Results from their Psilocybin R&D...

    atai

    Huge News on Opioid Addiction From atai (ATAI).

    Compass Pathways, Psychedelic Stock Review

    Compass Pathways (CMPS) Reports 2Q and Business Highlights.

    Atai Life Sciences (ATAI) Presentation Deck.

    Atai Life Sciences (ATAI)

    Compass Pathways (CMPS)

    MindMed (MNMD)

    Cybin (CYBN) Enters into Collaboration Agreement with Greenbrook TMS (GBNH) to...

    ©